S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

Sanntidsoppdatering for Oscotec Inc. [039200.KQ]

Børs: KOSDAQ
Sist oppdatert26 apr 2024 @ 08:30

0.00% KRW 30 200

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 08:30):

Oscotec Inc. operates as a clinical stage drug discovery and development company. It develops SYK inhibitor that is in Phase IIa clinical trial to treat rheumatoid arthritis and immune thrombocytopenia; FLT3 inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia; and EGFR double mutation inhibitor to treat non-small cell lung cancer, as well as Anti-Tau antibody, which is in preclinical Phase for the treatment of Alzheimer's disease...

Stats
Dagens volum 220 773
Gjennomsnittsvolum 489 261
Markedsverdi 1 147.42B
EPS KRW-279.60 ( 2024-03-18 )
Neste inntjeningsdato ( KRW0 ) 2024-05-09
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW58.95 (0.20%)

Volum Korrelasjon

Lang: -0.21 (neutral)
Kort: -0.24 (neutral)
Signal:(63.232) Neutral

Oscotec Inc. Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Oscotec Inc. Korrelasjon - Valuta/Råvare

The country flag -0.17
( neutral )
The country flag -0.20
( neutral )
The country flag 0.01
( neutral )
The country flag 0.06
( neutral )
The country flag 0.30
( neutral )
The country flag 0.02
( neutral )

Oscotec Inc. Økonomi

Annual 2023
Omsetning: KRW4.95B
Bruttogevinst: KRW1.23B (24.85 %)
EPS: KRW-634.86
FY 2023
Omsetning: KRW4.95B
Bruttogevinst: KRW1.23B (24.85 %)
EPS: KRW-634.86
FY 2022
Omsetning: KRW5.06B
Bruttogevinst: KRW1.57B (31.04 %)
EPS: KRW-763.19

Financial Reports:

No articles found.

Oscotec Inc.

Oscotec Inc. operates as a clinical stage drug discovery and development company. It develops SYK inhibitor that is in Phase IIa clinical trial to treat rheumatoid arthritis and immune thrombocytopenia; FLT3 inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia; and EGFR double mutation inhibitor to treat non-small cell lung cancer, as well as Anti-Tau antibody, which is in preclinical Phase for the treatment of Alzheimer's disease. The company also offers dental health products, such as bone graft comprising InduCera, BioCera-F, and SynCeraII; and membrane consisting of LysoGide and CollaGuide. In addition, it provides functional ingredients comprises OPB for osteoporosis; AIF for arthritis; SGA that enhance bone growth; and PRF-K for perio diseases. The company was formerly known as Oscotec Co., Ltd and changed its name to Oscotec Inc. in June 1999. Oscotec Inc. was founded in 1988 and is based in Seongnam, South Korea.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.